Vitamin D and calcium deficits predispose for multiple chronic diseases

European Journal of Clinical Investigation

Volumn 35, Issue 5, 2005, Pages 290-304

  Peterlik, Meinrad ^a   Cross, H S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

25 hydroxyvitamin D 1 hydroxylase; Autoimmune disease; Calcium status; Calcium sensing receptor; Cancer; Vitamin D insufficiency

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM SENSING RECEPTOR; VITAMIN D;

AUTOIMMUNE DISEASE; BONE TISSUE; BREAST CANCER; CALCIUM CELL LEVEL; CALCIUM DEFICIENCY; CANCER RISK; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CHRONIC DISEASE; CHRONIC INFLAMMATION; CLINICAL OBSERVATION; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EXTRACELLULAR FLUID; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; INTESTINE; KIDNEY PARENCHYMA; LIGAND BINDING; MALNUTRITION; MAMMARY GLAND; METABOLIC DISORDER; PANCREAS; PREVALENCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY;

AUTOIMMUNE DISEASES; CALCIUM; CALCIUM, DIETARY; CHRONIC DISEASE; COMMUNICABLE DISEASES; HUMANS; HYPERTENSION; MUSCULOSKELETAL DISEASES; NEOPLASMS; OSTEOPOROSIS; PREVALENCE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 18744411252     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01487.x     Document Type: Review

References (154)

1. Broadus A, E. Mineral balance and homeostasis. In: Favus MJ, editor. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Washington, DC: American Society for Bone and Mineral Research; 2003. pp.105-11.
2. 3: an overview. J Nutr 1995;125:1687S-9S.
3. Dawson-Hughes B, Harris SS, Dallal GE. Plasma calcidiol, season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 1997;65:67-71.
4. Pasco JA, Henry MJ, Kotowicz MA, Sanders KM, Seeman E, Pasco JR et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res 2004;19:752-8.
5. Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997;7:439-43.
6. Kudlacek S, Schneider B, Peterlik M, Leb G, Klaushofer K, Weber K et al. Normative data of bone mineral density in an unselected adult Austrian population. Eur J Clin Invest 2003;33:332-9.
7. Kudlacek S, Schneider B, Peterlik M, Leb G, Klaushofer K, Weber K et al. Assessment of vitamin D and calcium status in healthy adult Austrians. Eur J Clin Invest 2003;33:323-31.
8. Lamberg-Allardt CJ, Outila TA, Karkkainen MU, Rita HJ, Valsta LM. Vitamin D deficiency and bone health in healthy adults in Finland, could this be a concern in other parts of Europe? J Bone Miner Res 2001;16:2066-73.
9. Scharla SH. Prevalence of subclinical vitamin D deficiency in different European countries. Osteoporos Int 1998;8:S7-12.
10. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003;89:552-72.
11. 3 into their respective lactones. Endocrinology 1995;136:4195-203.
12. 3-1alpha-hydroxylase activity and regulation of side-chain metabolism. J Steroid Biochem Mol Biol 1997;62:21-8.
13. Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M. 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun 2001;285:1012-7.
14. 3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab 1985;60:960-6.
15. Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-Grand) 2003;49:277-300.
16. 2D/25-OH-D ratio in synovial fluid of patients with rheumatoid arthritis. Life Sci 1997;61:977-85.
17. Pillai S, Bikle DD, Elias PM. 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem 1988;263:5390-5.
18. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001;86:888-94.
19. Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Williams MC et al. Synthesis of 1,25-dihydroxyvitamin D (3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 2002;13:621-9.
20. Cross HS, Kallay E, Lechner D, Gerdenitsch W, Adlercreutz H, Armbrecht HJ. Phytoestrogens and vitamin D metabolism, a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J Nutr 2004;134:1207S-12S.
21. 3-24-hydroxylase expression in the mouse colon - relevance for colon tumor incidence and prevention. Bone 2003;33:S11.
22. Overbergh L, Decallonne B, Valckx D, Verstuyf A, Depovere J, Laureys J et al. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 2000;120:139-46.
23. 3-1alpha-hydroxylase expression in normal and malignant human colon. J Histochem Cytochem 2004;52:985-9.
24. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004;108:104-8.
25. Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 1991;128:1496-504.
26. Colston KW, Hansen CM. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 2002;9:45-59.
27. Cross HS, Pavelka M, Slavik J, Peterlik M. Growth control of human colon cancer cells by vitamin D and calcium in vitro. J Natl Cancer Inst 1992;84:1355-7.
28. Cross HS, Hulla W, Tong WM, Peterlik M. Growth regulation of human colon adenocarcinoma-derived cells by calcium, vitamin D and epidermal growth factor. J Nutr 1995;125:2004S-8S.
29. Hulla W, Kallay E, Krugluger W, Peterlik M, Cross HS. Growth control of human colon-adenocarcinoma-derived Caco-2 cells by vitamin-D compounds and extracellular calcium in vitro: relation to c-myc-oncogene and vitamin-D-receptor expression. Int J Cancer 1995;62:711-6.
30. Tong WM, Hofer H, Ellinger A, Peterlik M, Cross HS. Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth. Oncol Res 1999;11:77-84.
31. Cross HS. Vitamin D and colon cancer. In: Feldman D, Pike JW, Glorieux FH, editors. Vitamin D, Vol. 2, San Diego, CA: Elsevier;2004.pp. 1709-25.
32. Bowman T, Broome MA, Sinibaldi D, Wharton W, Pledger WJ, Sedivy JM et al. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc Natl Acad Sci USA 2001;98:7319-24.
33. Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey 1988-94. Am J Clin Nutr 2002;76:187-92.
34. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 1989;2:1176-8.
35. Holt PR, Arber N, Halmos B, Forde K, Kissileff H, McGlynn KA et al. Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol Biomarkers Prev 2002;11:113-9.
36. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004;13:1502-8.
37. Grant WB, Garland CF. A critical review of studies on Vitamin D in relation to colorectal cancer. Nutr Cancer 2004;48:115-23.
38. Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002;94:1867-75.
39. Grant WB. Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent results. Cancer Res 2003;164:371-7.
40. Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W, Reichrath J. Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent results. Cancer Res 2003;164:239-46.
41. 3. Cancer Epidemiol Biomarkers Prev 1998;7:391-5.
42. 3. Carcinogenesis 2004;25:1015-26.
43. Grant WB. An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer 2002;94:272-81.
44. Freedman DM, Dosemeci M, McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 2002;59:257-62.
45. Newmark HL, Suh N. Mechanistic hypothesis for the interaction of dietary fat, calcium and vitamin d in breast cancer. Med Hypoth Res 2004;1:67-75.
46. Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC. Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst 2002;94:1301-11.
47. 3. Stimulation of defective migration of AIDS patients. J Immunol 1990;145:2459-64.
48. 3. Calcif Tissue Int 1993;53:193-200.
49. 3 promotes in vitro morphologic and enzymatic changes in normal human monocytes consistent with their differentiation into macrophages. Bone 1986;7:23-8.
50. 3 and cytokines. J Leukoc Biol 1995;58:256-62.
51. 3 activates secretion of hydrogen peroxide by human monocytes. J Immunol 1986;136:1049-53.
52. 3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem 2001;276:35482-93.
53. 3 on mouse peritoneal macrophage functions. J Immunol 1989;143:3686-90.
54. Grant WB. Solar UV-B radiation is linked to the geographic variation of mortality from systemic lupus erythematosus in the USA. Lupus 2004;13:281-2.
55. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 1991;100:143-9.
56. Podolsky DK. Inflammatory bowel disease. N Engl J Med 1991;325:928-1016.
57. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500-3.
58. Merlino L, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis. Results from the Iowa Women's Health Study. Arthr Rheumat 2004;50:72-7.
59. Ponsonby AL, McMichael A, van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 2002;181-182:71-8.
60. Embry A. Vitamin D supplementation in the fight against multiple sclerosis. J Orthomol Med 2004;19:27-38.
61. Mathieu C, Adorini L. The coming of age of 1,25-dihydroxyvitamin D (3) analogs as immunomodulatory agents. Trends Mol Med 2002;8:174-9.
62. 3. J Neuroimmunol 1995;61:151-60.
63. Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000;130:2648-52.
64. 3: preferential inhibition of Th1 functions. J Nutr 1995;125:1704S-8S.
65. 3 as a natural regulator of human immune functions. J Invest Dermatol Symp Proc 1996;1:68-71.
66. 3. Kidney Int 1990;29:S9-16.
67. 3. Int Arch Allergy Immunol 2002;128:33-41.
68. 3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr Res 2002;52:12-8.
69. 3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab 1999;84:3739-44.
70. Waters WR, Palmer MV, Nonnecke BJ, Whipple DL, Horst RL. Mycobacterium bovis infection of vitamin D-deficient NOS2-/- mice. Microb Pathog 2004;36: 11-7.
71. Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000;355:618-21.
72. Davies PD, Brown RC, Woodhead JS. Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax 1985;40:187-90.
73. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin d receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003;17:2386-92.
74. Targan SR, Murphy LK. Clarifying the causes of Crohn's. Nat Med 1995;1:1241-3.
75. Farrell RJ, Peppercorn MA. Ulcerative colitis. Lancet 2002;359:331-40.
76. Greenstein RJ. Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis 2003;3:507-14.
77. Goldberg P. Multiple sclerosis; vitamin D and calcium as environmental determinants of prevalence. Part 1. Sunlight, dietary facrors and epidemiology. Int J Environ Studies 1974;6:19-27.
78. Goldberg P. Multiple sclerosis; vitamin D and calcium as environmental determinants of prevalence. Part 2. Biochemical and genetic factors. Int J Environ Studies 1974;6: 121-9.
79. Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 1986;21:193-200.
80. 3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 1996;93:7861-4.
81. Cantorna MT, Humpal-Winter J, DeLuca HF. Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J Nutr 1999;129:1966-71.
82. Giulietti A, Gysemans C, Stoffels K, Van Etten E, Decallonne B, Overbergh L et al. Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologia 2004,47:451-62.
83. 3. Diabetologia 1994;37:552-8.
84. 3. Curr Opin Nephrol Hypertens 1995;4:313-8.
85. 3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 1995;27:181-8.
86. Pietschmann P, Schernthaner G, Woloszczuk W. Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia 1988;31:892-5.
87. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-5.
88. Lind L, Hanni A, Lithell H, Hvarmer A, Sorensen OH, Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 1995;8:894-901.
89. Birge SJ, Haddad JG. 25-hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest 1975;56:1100-7.
90. Gagel RF. Mineral and vitamin D RDA for infants children and adults. In: Favus MJ, editor. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. New York: Raven Press;1993.p. 413.
91. Heaney RP. The importance of calcium intake for lifelong skeletal health. Calcif Tissue Int 2002;70:70-3.
92. Barrett-Connor E. The RDA for calcium in the elderly: too little, too late. Calcif Tissue Int 1989;44:303-7.
93. Obermayer-Pietsch B, Bonelli CM, Walter DE, Kuhn RJ, Fahrleitner-Pammer A, Berghold A et al. Genetic predisposition for adult lactose intolerance and relation to diet, bone density, and bone fractures. J Bone Miner Res 2004;19:42-7.
94. McCarron DA, Reusser ME. Finding consensus in the dietary calcium-blood pressure debate. J Am Coll Nutr 1999;18:398S-405S.
95. Lipkin M, Newmark HL. Vitamin D, calcium and prevention of breast cancer: a review. J Am Coll Nutr 1999;18:392S-7S.
96. Hayes RB, Ziegler RG, Gridley G, Swanson C, Greenberg RS, Swanson GM et al. Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol Biomarkers Prev 1999;8:25-34.
97. Lipkin M, Newmark H, Boone CW, Kelloff GJ. Calcium, vitamin D, and colon cancer. Cancer Res 1991;51:3069-70.
98. Mathieu C, Van Etten E, Gysemans C, Decallonne B, Kato S, Laureys J et al. In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J Bone Miner Res 2001;16:2057-65.
99. Olszak IT, Poznansky MC, Evans RH, Olson D, Kos C, Pollak MR et al. Extracellular calcium elicits a chemokinetic response from monocytes in vitro and in vivo. J Clin Invest 2000;105:1299-305.
100. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O et al. Cloning and characterization of an extracellular Ca (2+)-sensing receptor from bovine parathyroid. Nature 1993;366:575-80.
101. 2+)-sensing receptor in the clonal osteoblast-like cell lines, UMR-106 and SAOS-2. Biochem Biophys Res Commun 1998;243:753-7.
102. Kállay E, Kifor O, Chattopadhyay N, Brown EM, Bischof MG, Peterlik M et al. Calcium-dependent c-myc proto-oncogene expression and proliferation of Caco-2 cells: a role for a luminal extracellular calcium-sensing receptor. Biochem Biophys Res Commun 1997;232:80-3.
103. Kállay E, Bajna E, Wrba F, Kriwanek S, Peterlik M, Cross HS. Dietary calcium and growth modulation of human colon cancer cells: role of the extracellular calcium-sensing receptor. Cancer Detect Prev 2000;24:127-36.
104. Yamaguchi T, Olozak I, Chattopadhyay N, Butters RR, Kifor O, Scadden DT et al. Expression of extracellular calcium (Ca2+o)-sensing receptor in human peripheral blood monocytes. Biochem Biophys Res Commun 1998;246:501-6.
105. Kallay E, Bonner E, Wrba F, Thakker RV, Peterlik M, Cross HS. Molecular and functional characterization of the extracellular calcium-sensing receptor in human colon cancer cells. Oncol Res 2003;13:551-9.
106. Chattopadhyay N, Brown EM. Calcium-sensing Receptor. Boston: Kluwer Academic Publishers, 2003.
107. Riggs BL, Khosla S, Melton LJ, 3rd. A unitary model for involutional osteoporosis, estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998;13:763-73.
108. 2+ sensing by the osteoblast-like cell line, MC3T3-E1. Cell Calcium 1994;15:447-56.
109. Quarles LD, Hartle JE, 2nd Siddhanti SR, Guo R, Hinson TK. A distinct cation-sensing mechanism in MC3T3-E1 osteoblasts functionally related to the calcium receptor. J Bone Miner Res 1997;12:393-402.
110. 2+)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells. J Bone Miner Res 1998;13:1530-8.
111. Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990;323:878-83.
112. Elders PJ, Lips P, Netelenbos JC, van Ginkel FC, Khoe E, van der Vijgh WJ et al. Long-term effect of calcium supplementation on bone loss in perimenopausal women. J Bone Miner Res 1994;9:963-70.
113. Recker RR, Hinders S, Davies KM, Heaney RP, Stegman MR, Lappe JM et al. Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 1996;11:1961-6.
114. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-6.
115. 3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637-42.
116. Larsen ER, L.Mosekilde, A.Foldspang. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004;19:370-8.
117. Favero A, Parpinel M, Franceschi S. Diet and risk of breast cancer: major findings from an Italian case-control study. Biomed Pharmacother 1998;52:109-15.
118. Yang CY, Chiu HF, Cheng MF, Hsu TY, Wu TN. Calcium and magnesium in drinking water and the risk of death from breast cancer. J Toxicol Environ Health A 2000;60:231-41.
119. Grant WB. An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer 2002;94:272-81.
120. Garland C, Shekelle RB, Barren-Connor E, Criqui MH, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985;1:307-9.
121. Garland CF, Garland FC, Gorham ED. Can colon cancer incidence and death rates be reduced with calcium and vitamin D? Am J Clin Nutr 1991;54:193S-201S.
122. Martinez ME, Willett WC. Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 1998;7:163-8.
123. Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med 1985;313:1381-4.
124. Lipkin M, Friedman E, Winawer SJ, Newmark H. Colonic epithelial cell proliferation in responders and nonresponders to supplemental dietary calcium. Cancer Res 1989;49:248-54.
125. Holt PR, Atillasoy EO, Oilman J, Guss J, Moss SF, Newmark H et al. Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: a randomized controlled trial. JAMA 1998;280:1074-9.
126. Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL. Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst 2002;94:437-46.
127. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985;1:307-9.
128. Martinez ME, Willett WC. Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 1998;7:163-8.
129. Lipkin M, Newmark H. Effect of added dietary calcium on colonie epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med 1985;313:1381-4.
130. Lipkin M, Friedman E, Winawer SJ, Newmark H. Colonic epithelial cell proliferation in responders and nonresponders to supplemental dietary calcium. Cancer Res 1989;49:248-54.
131. Holt PR, Atillasoy EO, Gilman J, Guss J, Moss SF, Newmark H et al. Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: a randomized controlled trial. Jama 1998;280:1074-9.
132. 3 and its analogs on human colon adenocarcinoma cells (CaCo-2): influence of extracellular calcium. Biochem Biophys Res Commun 1991;179:57-62.
133. 2+-sensing receptors in intestinal epithelium. Am J Physiol 1997;273:C1168-75.
134. Sheinin Y, Kallay E, Wrba F, Kriwanek S, Peterlik M, Cross HS. Immunocytochemical localization of the extracellular calcium-sensing receptor in normal and malignant human large intestinal mucosa. J Histochem Cytochem 2000;48:595-602.
135. Whitfield JF. Calcium: Cell Cycle Driver, Differentiator and Killer. New York: Chapman & Hall, 1997.
136. Chattopadhyay N, Cheng I, Rogers K, Riccardi D, Hall A, Diaz R et al. Identification and localization of extracellular Ca (2+)-sensing receptor in rat intestine. Am J Physiol 1998;274:G122-30.
137. McGrath CM, Soule HD. Calcium regulation of normal human mammary epithelial cell growth in culture. In Vitro 1984;20:652-62.
138. Cheng I, Klingensmith ME, Chattopadhyay N, Kifor O, Butters RR, Soybel DI et al. Identification and localization of the extracellular calcium-sensing receptor in human breast. J Clin Endocrinol Metab 1998;83:703-7.
139. McCarron DA, Lipkin M, Rivlin RS, Heaney RP. Dietary calcium and chronic diseases. Med Hypotheses 1990;31:265-73.
140. McCarron DA. Calcium and magnesium nutrition in human hypertension. Ann Intern Med 1983;98:800-5.
141. Ayachi S. Increased dietary calcium lowers blood pressure in the spontaneously hypertensive rat. Metabolism 1979;28:1234-8.
142. Belizan JM, Pineda O, Sainz E, Menendez LA, Villar J. Rise of blood pressure in calcium-deprived pregnant rats. Am J Obstet Gynecol 1981;141:163-9.
143. McCarron DA. Low serum concentrations of ionized calcium in patients with hypertension. N Engl J Med 1982;307:226-8.
144. McCarron DA, Morris CD. Blood pressure response to oral calcium in persons with mild to moderate hypertension. A randomized, double-blind, placebo-controlled, crossover trial. Ann Intern Med 1985;103:825-31.
145. Wang D, An SJ, Wang WH, McGiff JC, Ferreri NR. CaR-mediated COX-2 expression in primary cultured mTAL cells. Am J Physiol Renal Physiol 2001;281:F658-64.
146. Malloy PJ, Pike JW, Feldman D. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Rev 1999;20:156-88.
147. Grau MV, Baron JA, Sandier RS, Haile RW, Beach ML, Church TR et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003;95:1765-71.
148. Kállay E, Y.Sheinin M, Peterlik HS, Cross. Hormonal regulation of the expression of an extracellular calcium sensing receptor in human colon cancer cells. Bone 1998;22:42S.
149. Canaff L, Hendy GN. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem 2002;277:30337-50.
150. McNeil L, Hobson S, Nipper V, Rodland KD. Functional calcium-sensing receptor expression in ovarian surface epithelial cells. Am J Obstet Gynecol 1998;178:305-13.
151. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Brown EM. Ca (2+)-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab 2001;281:E1267-74.
152. Squires PE, Harris TE, Persaud SJ, Curtis SB, Buchan AM, Jones PM. The extracellular calcium-sensing receptor on human beta-cells negatively modulates insulin secretion. Diabetes 2000;49:409-17.
153. Racz GZ, Kittel A, Riccardi D, Case RM, Elliott AC, Varga G. Extracellular calcium sensing receptor in human pancreatic cells. Gut 2002;51:705-11.
154. Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S et al. 25-Hydroxyvitamin D-3-1 alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 2001;66:287-92.